Cardiac myosin binding protein-C: a potential early-stage, cardiac-specific biomarker of ischemia-reperfusion injury.
作者信息
Sadayappan Sakthivel
出版信息
Biomark Med. 2012 Feb;6(1):69-72. doi: 10.2217/bmm.11.100.
Abstract
摘要
相似文献
1
Cardiac myosin binding protein-C: a potential early-stage, cardiac-specific biomarker of ischemia-reperfusion injury.心肌肌球蛋白结合蛋白-C：一种潜在的早期心脏特异性缺血再灌注损伤生物标志物。
Biomark Med. 2012 Feb;6(1):69-72. doi: 10.2217/bmm.11.100.
2
Cardiomyocyte-Specific JunD Overexpression Increases Infarct Size following Ischemia/Reperfusion Cardiac Injury by Downregulating Sirt3.心肌细胞特异性 JunD 过表达通过下调 Sirt3 增加缺血/再灌注心脏损伤后的梗死面积。
Thromb Haemost. 2020 Jan;120(1):168-180. doi: 10.1055/s-0039-3400299. Epub 2019 Dec 13.
3
Cardiac Electrophysiological Changes and Downregulated Connexin 43 Prompts Reperfusion Arrhythmias Induced by Hypothermic Ischemia-Reperfusion Injury in Isolated Rat Hearts.低温缺血再灌注损伤诱导的孤立大鼠心脏复灌心律失常与心脏电生理变化及缝隙连接蛋白 43 下调有关。
J Cardiovasc Transl Res. 2022 Dec;15(6):1464-1473. doi: 10.1007/s12265-022-10256-7. Epub 2022 Jun 10.
4
Pathogenic properties of the N-terminal region of cardiac myosin binding protein-C in vitro.心肌肌球蛋白结合蛋白 C N 端结构域在体外的致病特性。
J Muscle Res Cell Motil. 2012 May;33(1):17-30. doi: 10.1007/s10974-012-9292-y. Epub 2012 Apr 17.
5
Ablation of the calpain-targeted site in cardiac myosin binding protein-C is cardioprotective during ischemia-reperfusion injury.钙蛋白酶靶向心肌肌球蛋白结合蛋白-C 位点的消融在缺血再灌注损伤期间具有心脏保护作用。
J Mol Cell Cardiol. 2019 Apr;129:236-246. doi: 10.1016/j.yjmcc.2019.03.006. Epub 2019 Mar 9.
6
Identification of cardiac myosin-binding protein C as a candidate biomarker of myocardial infarction by proteomics analysis.通过蛋白质组学分析鉴定心肌肌球蛋白结合蛋白 C 作为心肌梗死的候选生物标志物。
Mol Cell Proteomics. 2009 Dec;8(12):2687-99. doi: 10.1074/mcp.M900176-MCP200. Epub 2009 Aug 31.
7
Blockade of Hsp20 phosphorylation exacerbates cardiac ischemia/reperfusion injury by suppressed autophagy and increased cell death.热休克蛋白20（Hsp20）磷酸化的阻断通过抑制自噬和增加细胞死亡加重心脏缺血/再灌注损伤。
Circ Res. 2009 Dec 4;105(12):1223-31. doi: 10.1161/CIRCRESAHA.109.200378. Epub 2009 Oct 22.
8
Regulation of cardiac and renal ischemia-reperfusion injury by microRNAs.miRNAs 调控心脏和肾脏缺血再灌注损伤。
Free Radic Biol Med. 2013 Sep;64:78-84. doi: 10.1016/j.freeradbiomed.2013.06.044. Epub 2013 Jul 8.
9
Altered expression of calcineurin, calpain, calpastatin and HMWCaMBP in cardiac cells following ischemia and reperfusion.缺血再灌注后心肌细胞中钙调神经磷酸酶、钙蛋白酶、钙蛋白酶抑制蛋白和高分子量钙调结合蛋白的表达改变。
Biochem Biophys Res Commun. 2014 Jan 10;443(2):604-9. doi: 10.1016/j.bbrc.2013.12.019. Epub 2013 Dec 11.
10
Nitric oxide synthase-independent generation of nitric oxide in muscle ischemia--reperfusion injury.肌肉缺血-再灌注损伤中不依赖一氧化氮合酶的一氧化氮生成
Nitric Oxide. 2000 Dec;4(6):541-5. doi: 10.1006/niox.2000.0308.
引用本文的文献
1
Reference values and biological determinants for cardiac myosin-binding protein C concentrations assessed with an enzyme-linked immunosorbent assay.用酶联免疫吸附测定法评估心肌肌球蛋白结合蛋白C浓度的参考值和生物学决定因素。
J Med Biochem. 2023 Oct 27;42(4):665-674. doi: 10.5937/jomb0-39081.
2
Modifications of myofilament protein phosphorylation and function in response to cardiac arrest induced in a swine model.猪模型中因心脏骤停引起的肌丝蛋白磷酸化和功能的改变。
Front Physiol. 2015 Jul 16;6:199. doi: 10.3389/fphys.2015.00199. eCollection 2015.
3
Top-down mass spectrometry of cardiac myofilament proteins in health and disease.健康与疾病状态下心肌肌丝蛋白的自上而下质谱分析
Proteomics Clin Appl. 2014 Aug;8(7-8):554-68. doi: 10.1002/prca.201400043.
4
Surviving the infarct: A profile of cardiac myosin binding protein-C pathogenicity, diagnostic utility, and proteomics in the ischemic myocardium.梗死心肌中的存活：心肌肌球蛋白结合蛋白C的致病性、诊断效用及缺血心肌蛋白质组学概况
Proteomics Clin Appl. 2014 Aug;8(7-8):569-77. doi: 10.1002/prca.201400011. Epub 2014 Jul 14.
5
Release kinetics of circulating cardiac myosin binding protein-C following cardiac injury.心肌肌球蛋白结合蛋白 C 在心损伤后的循环释放动力学。
Am J Physiol Heart Circ Physiol. 2014 Feb 15;306(4):H547-56. doi: 10.1152/ajpheart.00846.2013. Epub 2013 Dec 13.
6
Novel control of cardiac myofilament response to calcium by S-glutathionylation at specific sites of myosin binding protein C.肌球蛋白结合蛋白 C 特定位点的 S-谷胱甘肽化对心肌肌丝钙反应的新型调控。
Front Physiol. 2013 Nov 20;4:336. doi: 10.3389/fphys.2013.00336. eCollection 2013.
7
Cardiac myosin binding protein-C as a central target of cardiac sarcomere signaling: a special mini review series.心肌球蛋白结合蛋白 C 作为心肌肌节信号转导的中心靶点：一个特别的小型综述系列。
Pflugers Arch. 2014 Feb;466(2):195-200. doi: 10.1007/s00424-013-1396-8. Epub 2013 Nov 7.
8
A sensitive and specific quantitation method for determination of serum cardiac myosin binding protein-C by electrochemiluminescence immunoassay.一种通过电化学发光免疫分析法测定血清心肌肌球蛋白结合蛋白-C的灵敏且特异的定量方法。
J Vis Exp. 2013 Aug 8(78):50786. doi: 10.3791/50786.
9
Increase in cardiac myosin binding protein-C plasma levels is a sensitive and cardiac-specific biomarker of myocardial infarction.心肌肌球蛋白结合蛋白-C血浆水平升高是心肌梗死的一种敏感且具有心脏特异性的生物标志物。
Am J Cardiovasc Dis. 2013 Jun 10;3(2):60-70. Print 2013.
10
Pathogenic properties of the N-terminal region of cardiac myosin binding protein-C in vitro.心肌肌球蛋白结合蛋白 C N 端结构域在体外的致病特性。
J Muscle Res Cell Motil. 2012 May;33(1):17-30. doi: 10.1007/s10974-012-9292-y. Epub 2012 Apr 17.
本文引用的文献
1
Cardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction.心肌肌球蛋白结合蛋白 C 是心肌梗死的潜在诊断生物标志物。
J Mol Cell Cardiol. 2012 Jan;52(1):154-64. doi: 10.1016/j.yjmcc.2011.09.011. Epub 2011 Sep 19.
2
Direct visualization of myosin-binding protein C bridging myosin and actin filaments in intact muscle.直接观察肌球蛋白结合蛋白 C 在完整肌肉中连接肌球蛋白和肌动蛋白丝。
Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11423-8. doi: 10.1073/pnas.1103216108. Epub 2011 Jun 24.
3
A critical function for Ser-282 in cardiac Myosin binding protein-C phosphorylation and cardiac function.丝氨酸 282 在心肌肌球蛋白结合蛋白 C 磷酸化和心脏功能中的关键作用。
Circ Res. 2011 Jul 8;109(2):141-50. doi: 10.1161/CIRCRESAHA.111.242560. Epub 2011 May 19.
4
Targeted mass spectrometry approaches for protein biomarker verification.靶向质谱法在蛋白质生物标志物验证中的应用。
J Proteomics. 2011 Nov 18;74(12):2650-9. doi: 10.1016/j.jprot.2011.04.011. Epub 2011 Apr 21.
5
Deglycosylation and label-free quantitative LC-MALDI MS applied to efficient serum biomarker discovery of lung cancer.聚糖水解和无标记定量 LC-MALDI MS 应用于肺癌高效血清生物标志物的发现。
Proteome Sci. 2011 Apr 8;9:18. doi: 10.1186/1477-5956-9-18.
6
Intact protein separation by one- and two-dimensional liquid chromatography for the comparative proteomic separation of partitioned serum or plasma.通过一维和二维液相色谱法进行完整蛋白质分离，用于分区血清或血浆的比较蛋白质组学分离。
Methods Mol Biol. 2011;728:29-46. doi: 10.1007/978-1-61779-068-3_2.
7
2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2011年美国心脏病学会基金会/美国心脏协会实践指南工作组对不稳定型心绞痛/非ST段抬高型心肌梗死患者管理指南的聚焦更新（更新2007年指南）
Circulation. 2011 May 10;123(18):2022-60. doi: 10.1161/CIR.0b013e31820f2f3e. Epub 2011 Mar 28.
8
Overview: the maturing of proteomics in cardiovascular research.概述：蛋白质组学在心血管研究中的成熟。
Circ Res. 2011 Feb 18;108(4):490-8. doi: 10.1161/CIRCRESAHA.110.226894.
9
Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI.ST段抬高型心肌梗死和非 ST 段抬高型心肌梗死患者的发病率、治疗和结局的最新趋势。
Am J Med. 2011 Jan;124(1):40-7. doi: 10.1016/j.amjmed.2010.07.023.
10
Heart disease and stroke statistics--2011 update: a report from the American Heart Association.心脏病和中风统计数据--2011 年更新：来自美国心脏协会的报告。
Circulation. 2011 Feb 1;123(4):e18-e209. doi: 10.1161/CIR.0b013e3182009701. Epub 2010 Dec 15.
Zotero 插件